{"id":1876,"date":"2013-06-12T17:36:59","date_gmt":"2013-06-12T17:36:59","guid":{"rendered":"https:\/\/www.lymphoma.ca\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/"},"modified":"2013-06-12T17:36:59","modified_gmt":"2013-06-12T17:36:59","slug":"ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/","title":{"rendered":"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante"},"content":{"rendered":"<p>Lymphome Canada se f\u00e9licite de la d\u00e9cision du gouvernement de l\u2019Ontario d\u2019\u00e9largir les crit\u00e8res de remboursement du principe actif rituximab (nom de marque Rituxan)<br \/>\n<!--more--><\/p>\n<p>Lymphome Canada se f\u00e9licite de la d\u00e9cision du gouvernement de l\u2019Ontario d\u2019\u00e9largir les crit\u00e8res de remboursement du principe actif rituximab (nom de marque Rituxan) afin de permettre la prise en charge des patients atteints de leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante.<\/p>\n<p>Depuis le 31 mai 2013, Rituxan figure sur le formulaire du programme des m\u00e9dicaments gratuits de l\u2019Ontario en d\u00e9finissant les crit\u00e8res suivants&nbsp;:<\/p>\n<ul>\n<li>Rituximab&nbsp;est utilis\u00e9 dans le traitement de deuxi\u00e8me ligne de la leuc\u00e9mie lympho\u00efde chronique r\u00e9cidivante ou r\u00e9fractaire, en association avec un traitement \u00e0 base de fludarabine (ceci signifie que le patient est \u00e9ligible \u00e0 une th\u00e9rapie contenant de la fludarabine).<\/li>\n<li>Le patient est \u00e9tranger au traitement \u00e0 base de rituximab (ceci signifie que le patient n\u2019a jamais suivi de traitement contenant du rituximab pour soigner une leuc\u00e9mie lympho\u00efde chronique).<\/li>\n<\/ul>\n<p>La d\u00e9cision d\u2019ajouter rituximab \u00e0 la liste du r\u00e9gime provincial d\u2019assurance-m\u00e9dicaments pour ce type de traitement signifie que des patients atteints de LLC r\u00e9cidivante r\u00e9sidant&nbsp; en Ontario auront d\u00e9sormais acc\u00e8s \u00e0 ce traitement offert aux Canadiens dans les autres provinces.<\/p>\n<p>Si vous avez des questions concernant ces crit\u00e8res ou tout autre type de m\u00e9dication, nous vous prions de vous adresser directement \u00e0 votre m\u00e9decin traitant.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lymphome Canada se f\u00e9licite de la d\u00e9cision du gouvernement de l\u2019Ontario d\u2019\u00e9largir les crit\u00e8res de remboursement du principe actif rituximab (nom de marque Rituxan)<\/p>\n","protected":false},"author":1,"featured_media":1771,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10,17],"tags":[],"class_list":{"0":"post-1876","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nouvelles","8":"category-recherche"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante - Lymphoma Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante - Lymphoma Canada\" \/>\n<meta property=\"og:description\" content=\"Lymphome Canada se f\u00e9licite de la d\u00e9cision du gouvernement de l\u2019Ontario d\u2019\u00e9largir les crit\u00e8res de remboursement du principe actif rituximab (nom de marque Rituxan)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-12T17:36:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\"},\"headline\":\"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante\",\"datePublished\":\"2013-06-12T17:36:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/\"},\"wordCount\":272,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"articleSection\":[\"Nouvelles\",\"Recherche\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/\",\"name\":\"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante - Lymphoma Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"datePublished\":\"2013-06-12T17:36:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg\",\"width\":700,\"height\":300,\"caption\":\"masthead_ph_shadows\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lymphoma.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LymphomaCanada\",\"https:\/\/x.com\/lymphomacanada\",\"https:\/\/www.linkedin.com\/company\/lymphoma-canada\/\",\"http:\/\/instagram.com\/lymphomacanada\",\"http:\/\/www.youtube.com\/user\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante - Lymphoma Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/","og_locale":"fr_FR","og_type":"article","og_title":"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante - Lymphoma Canada","og_description":"Lymphome Canada se f\u00e9licite de la d\u00e9cision du gouvernement de l\u2019Ontario d\u2019\u00e9largir les crit\u00e8res de remboursement du principe actif rituximab (nom de marque Rituxan)","og_url":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2013-06-12T17:36:59+00:00","og_image":[{"width":700,"height":300,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/"},"author":{"name":"admin","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4"},"headline":"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante","datePublished":"2013-06-12T17:36:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/"},"wordCount":272,"commentCount":0,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","articleSection":["Nouvelles","Recherche"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/","url":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/","name":"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante - Lymphoma Canada","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","datePublished":"2013-06-12T17:36:59+00:00","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/04\/masthead_ph_shadows.jpg","width":700,"height":300,"caption":"masthead_ph_shadows"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/ontario-rembourse-le-medicament-rituximab-lors-du-traitement-de-la-leucemie-lymphoide-chronique-llc-recidivante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Ontario rembourse le m\u00e9dicament rituximab lors du traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC) r\u00e9cidivante"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=1876"}],"version-history":[{"count":0,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1876\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/1771"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=1876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=1876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=1876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}